Why the study?
Does warfarin (target INR 2.0 to 3.0) prevent systemic emboli in patients with dilated cardiomyopathy and sinus rhythm without left ventricular thrombus?
Does warfarin (target INR 2.0 to 3.0) prevent systemic emboli in patients with dilated cardiomyopathy and sinus rhythm without left ventricular thrombus?
This article uses a clinical scenario of a patient with dilated cardiomyopathy in sinus rhythm to illustrate how to search the medical literature for evidence on anticoagulation.
Answers are grounded in this paper and cite their sources.
Guides clinicians in evidence retrieval for anticoagulation decisions in dilated cardiomyopathy; leaves open optimal management pending further trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Andrew D Oxman (1993) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: